Richard Schulick

Richard Schulick

University of Colorado Denver

H-index: 120

North America-United States

About Richard Schulick

Richard Schulick, With an exceptional h-index of 120 and a recent h-index of 72 (since 2020), a distinguished researcher at University of Colorado Denver, specializes in the field of Surgery, Immunology, Oncology, Pancreatic Disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer

Tumor Size And Not Radiologic Splenic Vessel Involvement Is Predictive Of Survival In Resectable Distal Pancreatic Cancer

Neoadjuvant chemotherapy versus upfront surgery for resectable pancreatic adenocarcinoma: an updated nationwide study

The association between social vulnerability and oncologic stage and treatment in the United States

ASO Visual Abstract: Adjuvant Chemotherapy with or Without Radiotherapy for Resected Pancreatic Cancer Following Multiagent Neoadjuvant Chemotherapy

Learning Curve of a Laparoscopic Pancreaticoduodenectomy Program at a Second Institution

The United States experience with diagnosing and treating esophageal cancer during the SARS‐CoV‐2 pandemic: A retrospective cohort study

Group XIV C-type lectins: emerging targets in tumor angiogenesis

Richard Schulick Information

University

Position

Professor and Chair of Department of Surgery and Cancer Center Director

Citations(all)

64887

Citations(since 2020)

30252

Cited By

48274

hIndex(all)

120

hIndex(since 2020)

72

i10Index(all)

310

i10Index(since 2020)

258

Email

University Profile Page

Google Scholar

Richard Schulick Skills & Research Interests

Surgery

Immunology

Oncology

Pancreatic Disease

Top articles of Richard Schulick

Tumor Size And Not Radiologic Splenic Vessel Involvement Is Predictive Of Survival In Resectable Distal Pancreatic Cancer

European Journal of Surgical Oncology

2024/2/1

Neoadjuvant chemotherapy versus upfront surgery for resectable pancreatic adenocarcinoma: an updated nationwide study

Annals of Surgery

2024/2/1

The association between social vulnerability and oncologic stage and treatment in the United States

Surgical Oncology Insight

2024/6/1

ASO Visual Abstract: Adjuvant Chemotherapy with or Without Radiotherapy for Resected Pancreatic Cancer Following Multiagent Neoadjuvant Chemotherapy

Annals of surgical oncology

2024/4/26

Learning Curve of a Laparoscopic Pancreaticoduodenectomy Program at a Second Institution

The American Surgeon™

2024/4/8

The United States experience with diagnosing and treating esophageal cancer during the SARS‐CoV‐2 pandemic: A retrospective cohort study

International Journal of Cancer

2024/4/1

Group XIV C-type lectins: emerging targets in tumor angiogenesis

2024/3/12

Social Vulnerability Is Associated With Increased Oncologic Stage and Differences in Treatment Amongst Cancers in the United States

The Journal of Thoracic and Cardiovascular Surgery

2023/10/1

Social vulnerability is associated with higher risk-adjusted rates of postoperative complications in a broad surgical population

The American Journal of Surgery

2024/3/1

Management and outcomes of mixed adenoneuroendocrine carcinoma of the ampulla of Vater: A systematic review and pooled analysis of 56 patients

2023/4/1

Evaluation of Survival Following Surgical Resection for Small Nonfunctional Pancreatic Neuroendocrine Tumors

JAMA Network Open

2023/3/1

Prevalence and progression of intraductal papillary mucinous neoplasms of the pancreas in solid organ transplant recipients: A systematic review

2023/3/1

Association of adjuvant chemotherapy in patients with resected pancreatic adenocarcinoma after multiagent neoadjuvant chemotherapy

JAMA oncology

2023/3/1

Comparison of Invasive Pancreatic Ductal Adenocarcinoma versus Intraductal Papillary Mucinous Neoplasm: A National Cancer Database Analysis

Cancers

2023/2/13

Multiagent neoadjuvant chemotherapy compared to upfront surgery in pancreatic cancer of the body and tail using the National Cancer Database.

2023/2/1

Evaluating surgical treatment options for small nonfunctional pancreatic neuroendocrine tumors in the NCDB.

2023/2/1

Pathological features associated with lymph node disease in patients with appendiceal neuroendocrine tumors.

2023/2/1

Addition and timing of surgery in multiagent chemotherapy treatment of metastatic pancreatic cancer

HPB

2023/1/1

Analyzing the impact of the Coronavirus disease 2019 pandemic on initial oncologic presentation and treatment of non–small cell lung cancer in the United States

The Journal of Thoracic and Cardiovascular Surgery

2023/11/21

See List of Professors in Richard Schulick University(University of Colorado Denver)

Co-Authors

academic-engine